Phase II Open Label, Randomized, Controlled Study to Evaluate Safety and Immunogenicity of VPM1002 in Comparison With BCG in HIV-unexposed, BCG Naive Newborn Infants in South Africa.
Phase of Trial: Phase II
Latest Information Update: 01 Feb 2017
At a glance
- Drugs Tuberculosis vaccine (Primary) ; BCG vaccine
- Indications Tuberculosis
- Focus Adverse reactions
- Sponsors Vakzine Projekt Management
- 10 Jun 2017 Biomarkers information updated
- 30 May 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 02 Dec 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.